Doing More in Prognosis and Diagnosis
The project DoMore! aims to achieve better and faster diagnosis and prognosis with information and communication technology solutions.
Technological innovation brightens the future ahead. With an increase in investment towards these areas, we create not only further potential in the technological field, but see betterment in the area it was produced for – such as productivity, reliability, effectiveness and so on. This is great news, especially in terms of cancer treatment where continuous betterment is essential. But how, and to what effect, is this done?
Project DoMore! has the answers.
The project, funded by the Norwegian Research Council and including members of Oslo Cancer Cluster’s team, debates the future of doing more with modernized thinking.
How do they do it?
This is done by putting more effort into research and development of information and communication technology solutions to supplement, or even replace, methods in pathology: the study of causality in diseases. DoMore!, in this case, will increase productivity and quality of cancer treatment.
Close-up of a cancerous tumour within the intestine. The green line represents manual marking of the tumour, while the blue is automated. Photo: Institute for Cancer Genetics and Informatics
The Ambition
The goal, then, is to decrease the slight human error brought on by complex decision making and visual observation to a computer basis with unbiased, reproducible and greater accuracy in algorithms. By doing this, DoMore! hopes to increase efficiency in pathology, methods and markers to aid the clinician in giving better and more personalised treatment to cancer patients everywhere.
On top of this, DoMore! believes the same efficiency will apply to patents, publications, products and spin-off companies, as well as decreasing overall cost and treatment time.
Harbinger of Innovation
In regards to the importance of this project, Ketil Widerberg, who is General Manager of Oslo Cancer Cluster, highlights:
– Project DoMore! furthers the innovative process. This combination of biology and technology will become increasingly important, especially in the area of pathology. Ultimately, Project DoMore! is setting a great example of being the harbinger of our adapting future.
Targeting the Big Three
As of now, project DoMore! will be focusing on three major cancer forms: lung, colorectal and prostate cancer. These account for 44% of all deaths brought on by cancer and are amongst the most common.
Better Prognosis and Diagnosis Ahead
Undoubtedly, project DoMore! is set out to achieve great things. Already within the bright future of 2021, they hope to offer much securer and faster systems for diagnosis and prognosis amongst cancer patients.
